Bioethics, Ltd.
BOTH
$1.25
$0.70127.27%
OTC PK
| 09/30/2024 | 06/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 70.87% | -15.44% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 70.87% | -15.44% | |||
| Operating Income | -70.87% | 15.44% | |||
| Income Before Tax | -47.91% | 9.57% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -47.91% | 9.57% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -47.91% | 9.57% | |||
| EBIT | -70.87% | 15.44% | |||
| EBITDA | -- | -- | |||
| EPS Basic | -47.63% | 9.17% | |||
| Normalized Basic EPS | -47.47% | 9.17% | |||
| EPS Diluted | -47.63% | 9.17% | |||
| Normalized Diluted EPS | -47.47% | 9.17% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||